Hims vs Maximus: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Hims beats Maximus overall, scoring 7.9/10 vs 7.1/10. Hims is more affordable at $199/mo vs $300/mo. Choose Hims for men who want a well-known publicly-traded brand and fda-appr. Choose Maximus for men who want glp-1 alongside testosterone or other men's hea.
A side-by-side comparison of Hims and Maximus covering pricing, scores, medication types, insurance, and more to help you decide.
Hims
#12 of 48The household name in men's telehealth, publicly traded as Hims & Hers Health (NYSE: HIMS). In 2026 Hims added FDA-approved brand-name Wegovy (injection and pill) and Ozempic through a direct Novo Nordisk partnership — alongside their existing compounded semaglutide program. Brand recognition and product breadth are real strengths. The trade-off: Hims' verified Trustpilot rating is 3.0 stars across 8,286 reviews (May 2026) — significantly below smaller competitors like Henry Meds (4.5) or Eden Health (4.5). The 1-star pool is 28% — the highest 1-star rate in our table — clustered around subscription/billing complaints.
Visit HimsMaximus
#46 of 48Men's performance and health platform offering GLP-1 alongside testosterone optimization and other protocols.
Visit Maximus| Feature | Hims | Maximus |
|---|---|---|
| Our Score | 7.9/10 | 7.1/10 |
| Starting Price | $199/mo | $300/mo |
| Medication Type | Both | Compounded |
| Insurance Accepted | No | No |
| Best For | Men who want a well-known publicly-traded brand and FDA-approved Wegovy through the 2026 Novo Nordisk partnership — but should know going in that Hims' customer-experience signal is weaker than smaller competitors | Men who want GLP-1 alongside testosterone or other men's health protocols |
| Ranking | #12 | #46 |
Pros & Cons Compared
Hims
Pros
- +Publicly traded company (NYSE: HIMS) — SEC-filed financials, regulatory accountability that private competitors don't have.
- +2026 Novo Nordisk partnership — FDA-approved Wegovy injection, Wegovy pill, and Ozempic now available directly through Hims. Real brand-name access from a single platform.
- +$199/mo all-inclusive for compounded semaglutide, including consultations and shipping.
- +Polished app and web experience — among the best user interfaces in men's telehealth.
- +8,286 verified Trustpilot reviews is the second-largest review volume in our table (after Henry's 12,461) — significant real-world adoption.
Cons
- −Trustpilot rating is 3.0 stars / 8,286 reviews (May 2026) — significantly below Henry Meds (4.5), Eden Health (4.5), Yucca Health (4.6), MEDVi (4.4). The lowest customer-experience signal of any major brand we track.
- −28% of Trustpilot reviews are 1-star — the highest 1-star rate in our table. Top complaint themes: subscription handling, unexpected charges, customer service responsiveness.
- −Hims reviews span ALL their products (ED, hair loss, mental health, weight loss) — not just GLP-1. But the rating still applies because most users don't separate experiences by product.
- −'Hims Oral Kit' is NOT a GLP-1 — it's a non-GLP-1 metabolic combination (metformin + bupropion + topiramate + B12 + naltrexone). Easy to confuse with their compounded semaglutide. Read the product page carefully before signing up.
- −Brand Wegovy at $599/mo is not competitive with LillyDirect/NovoCare cash prices or with Hers ($149/mo for the same product via the same Novo partnership).
- −Generic high-volume support — large patient base means less personalized attention than smaller competitors.
Maximus
Pros
- +Lowest entry price in the market — $79.99/mo microdose semaglutide, $99.99/mo 3-month starter pack
- +GLP-1 microdosing available for BMI as low as 22 — the only platform serving patients below standard obesity criteria
- +Nausea-reducing formula with added glycine and B12 to ease GLP-1 side effects
- +Free expedited shipping on all medication orders
Cons
- −Deceptive pricing structure — $99.99/mo is intro only, standard dosing is $299.99/mo with separate $28-35 consultation fees and $199-349/yr lab costs
- −Refuses to disclose compounding pharmacy partners — a transparency red flag for a healthcare platform
- −Prices increase as dose escalates on bulk plans — unpredictable total cost over time
Our Verdict
Hims edges out Maximus with a score of 7.9/10 vs 7.1/10. If budget is your priority, Hims starts at $199/mo compared to Maximus's $300/mo. Hims offers both brand-name and compounded medications, giving you more flexibility. Choose Hims if you want: men who want a well-known publicly-traded brand and fda-approved wegovy through the 2026 novo nordisk partnership — but should know going in that hims' customer-experience signal is weaker than smaller competitors. Choose Maximus if you want: men who want glp-1 alongside testosterone or other men's health protocols.
Still undecided? Editor's #1 Overall Pick
Embody
$299/mo · 7.3/10 · Compounded
If neither Hims nor Maximus feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.
Read Full Reviews
Related comparisons
Other matchups readers comparing Hims or Maximus tend to look at next.
- Hims vs Hers$199/mo
- Hims vs Shed$199/mo
- Hims vs Henry Meds$199/mo
- Maximus vs Hone Health$309/mo
- Maximus vs MyStart Health$299/mo
- Maximus vs Direct Meds GLP-1$297/mo